MEDS - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים TRxADE Health Corp

TRxADE HEALTH management is seeking a profitable business model amid frequent strategy shifts. The year-over-year sales trajectory over the trailing four quarters visualizes this search, where -76.70 determines the latest valuation metric. The marketplace helps small pharmacies compete with tech giants, while financial stability relies on the volume of wholesale drug purchases by independent market participants.
TRxADE HEALTH, Inc. - פילוחים אנליטיים ומדדי מפתח (MEDS)

This indicator measures the percentage change in aggregate revenue over a rolling twelve-month period, effectively smoothing out market noise and separating real volume growth from inflationary impacts on revenue. By analyzing the year-over-year (LTM) gross revenue dynamics on the GURU.Markets platform, an investor can assess the effectiveness of the transformation of TRxADE HEALTH, Inc. (MEDS) from the pharmacy IT sector into a global food logistics operator.